期刊
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
卷 32, 期 -, 页码 40-45出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ejpn.2020.08.011
关键词
MED17; Pontocerebellar hypoplasia; Microcephaly; Founder mutation; Caucasus jews; Cerebral and cerebellar atrophy
The study examined patients with a homozygous founder mutation c.1112T>C in MED17 gene, leading to postnatal progressive microcephaly. Patients showed a unique clinical phenotype with severe intellectual disability, epilepsy, and progressive spasticity. MRI findings revealed marked cerebral and cerebellar atrophy in these patients.
Background: and Purpose: Postnatal progressive microcephaly, with seizures and brain atrophy (OMIM # 613668) is a rare disorder caused by a homozygous founder missense mutation c.1112T>C (p.L371P) in the MED17 gene on chromosome 11 that was identified in 2010 in Caucasus Jewish families. The present study aimed to delineate the phenotype and developmental outcomes in patients diagnosed with this mutation to date. Methods: We conducted a medical charts review to collect the clinical, laboratory and neuroimaging findings in patients from several unrelated families of Caucasus-Jewish origin, who were diagnosed with the same homozygous c.1112T>C MED17 mutation. Results: The study cohort, including the previously reported patients, comprised 10 males and 5 females from 11 families. All subjects had at birth a normal head circumference, which steeply declined to-6SD within a few months. None of the patients achieved developmental milestones. All patients had pro-gressive spasticity and were wheelchair bound due to spastic quadriplegia. All of them eventually developed profound intellectual disability. Epilepsy of varied severity was present in all patients. Most patients required enteral feeding due to aspirations. Eight patients died before puberty (age range 2-13 years). Brain MRI showed marked cerebral atrophy and early prominent cerebellar atrophy (vermian > hemispheres) accompanied by pontine ventral flattening. Conclusions: The founder c.1112T>C mutation in MED17 gene is expressed by a unique and homogeneous clinical phenotype with distinctive MRI findings. This mutation should be considered in patients of Caucasus-Jewish ancestry presenting with clinical features and a MRI pattern of progressive cerebral and cerebellar atrophy. (c) 2021 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据